What Businesses Should Know About the Patent Office's Nov. 2026 Changes

New patent review procedures could affect how businesses challenge competitors' patents and defend their own.

On November 10, 2026, the U.S. Patent and Trademark Office (USPTO) announced changes to how it evaluates challenges to issued patents. Effective November 16, the changes return certain patent review decisions to panels of administrative patent judges while establishing more explicit guidance for determining which challenges warrant a full proceeding.
For businesses that own patents, face allegations of infringement, or are considering challenging a competitor's patents, the changes could influence litigation strategies, costs, and negotiating leverage.
What Changed?
The USPTO's Patent Trial and Appeal Board (PTAB) conducts administrative proceedings that allow parties to challenge the patentability of issued patent claims. Two important procedures are inter partes review (IPR) and post-grant review (PGR).
These proceedings can provide alternatives to challenging patent validity in federal court. Under procedures adopted in October 2025, the USPTO Director centralized authority over decisions to institute these proceedings. The November 2026 changes return merits-based institution decisions to three-judge PTAB panels, while the Director retains initial authority to deny review based on non-merits considerations, including discretionary factors.
If the PTAB institutes review, a different panel of judges will conduct the trial.
The revised procedures apply to new petitions and pending proceedings that had not yet been referred for merits consideration when the changes took effect.
A More Demanding Review of Patent Challenges
Perhaps the most consequential aspect of the new guidance is its treatment of petitions challenging multiple patent claims. Under the America Invents Act, an IPR petition must establish a reasonable likelihood of prevailing against at least one challenged patent claim before review may be instituted. PGR proceedings generally require a showing that at least one challenged claim is more likely than not unpatentable, although a separate statutory provision permits institution based on certain novel or unsettled legal questions.
The November memorandum does not change these statutory thresholds. Instead, it directs PTAB panels to deny institution when a petitioner fails to make the necessary showing for a substantial majority of the challenged claims.
This approach has precedent. In earlier decisions, including Chevron Oronite Co. LLC v. Infineum USA L.P. (2018) and Deeper, UAB v. Vexilar, Inc. (2019), the PTAB declined to institute review where insufficient challenges satisfied the applicable standard. The November guidance expressly directs panels to follow this approach.
The reasoning also reflects the Supreme Court's decision in SAS Institute Inc. v. Iancu, 584 U.S. 357 (2018), which requires the USPTO to make an all-or-nothing institution decision on the petition rather than institute review of only selected challenged claims.
The practical consequences can be significant.
Consider a company challenging 12 claims of a competitor's patent. The company presents persuasive prior art against three claims but substantially weaker arguments against the remaining nine.
Although the strongest challenges might satisfy the statutory requirement concerning at least one claim, the petition could nevertheless be denied in its entirety because the petitioner failed to make the necessary showing for a substantial majority of the challenged claims.
The memorandum does not establish a precise numerical definition of a substantial majority, leaving an important question for future PTAB decisions.
When the Evidence Is Evenly Balanced
The November guidance also addresses how the PTAB should evaluate competing arguments at the institution stage.
When the arguments supporting and opposing unpatentability of a particular claim are both reasonably supported by the evidence, the memorandum instructs the PTAB not to treat the petitioner as having satisfied the applicable institution standard for that claim.
In other words, evenly balanced evidence does not favor the petitioner when applying the memorandum's substantial-majority analysis.
This matters because a patent owner may not need to conclusively establish the patentability of each disputed claim to defeat institution. A credible, well-supported response demonstrating substantial weaknesses in the petitioner's arguments may be sufficient to prevent review from proceeding.
For companies considering a patent challenge, the corresponding lesson is that merely identifying plausible invalidity arguments may not be enough. The petition must present a sufficiently persuasive case across the claims being challenged.
What This Means for Patent Owners
For businesses protecting valuable technology, the guidance may provide additional opportunities to resist challenges before expensive administrative trials begin.
A patent owner responding to an IPR petition may be able to defeat institution by demonstrating, through credible evidence and reasoned arguments, that the challenger has failed to satisfy the applicable standard for a substantial majority of the challenged claims.
This makes early evaluation of the asserted prior art especially important. Rather than focusing exclusively on defending the broadest claims, patent owners should examine whether the petition adequately addresses the limitations of narrower dependent claims.
Patent owners should also take advantage of the preliminary response process to identify deficiencies in the petitioner's evidence and reasoning.
The revised procedures do not, however, make patents immune from review. Well-supported challenges can still proceed, and the Director retains authority over discretionary institution decisions.
What This Means for Businesses Challenging Patents
For companies accused of patent infringement, or seeking to remove patent obstacles to commercialization, IPR and PGR proceedings remain potentially valuable tools.
But the new guidance reinforces the importance of evaluating the strength of a challenge before filing.
A petition built around one compelling invalidity argument, accompanied by weaker challenges to numerous additional claims, could face greater difficulty at the institution stage. The memorandum also emphasizes that petitioners relying on prior art must specifically explain how the cited references disclose or render obvious each limitation of each challenged claim. Generalized assertions or mere references to an examiner's prior findings are insufficient.
Companies contemplating patent challenges should therefore carefully consider which claims to challenge, whether the available prior art adequately supports each challenge, and whether an administrative proceeding offers advantages over litigating validity in federal court. These decisions can affect both the cost of a dispute and the company's ability to negotiate a favorable resolution.
What Businesses Should Do Now
Although the changes primarily concern patent disputes, they also have implications for companies managing valuable patent portfolios.
Patent owners should identify their commercially important claims and be prepared to evaluate asserted prior art promptly when a challenge arises. A well-supported preliminary response addressing weaknesses across multiple challenged claims may be particularly valuable under the new guidance.
Businesses facing infringement allegations should evaluate the available grounds for challenging patent validity before committing substantial resources to an IPR or PGR petition. Selecting the claims to challenge, and developing adequate evidentiary support for each, may be critical to obtaining review.
Companies negotiating patent licenses or acquisitions should consider how the revised institution procedures may affect the risks and costs of challenging the patents involved. A patent that is difficult to challenge administratively may carry different negotiating considerations from one vulnerable to a well-supported petition.
For both patent owners and challengers, the revised procedures reinforce the importance of undertaking a thorough validity analysis before selecting a litigation or licensing strategy.
The Bottom Line
The USPTO's November 2026 changes do not rewrite patent law. They alter how institution decisions are made and expressly reinforce an approach under which the strength of a challenge across multiple patent claims can determine whether an administrative review proceeds at all.
The ultimate effect on institution rates remains to be seen. Nevertheless, the guidance has immediate implications for how patent challenges should be prepared and defended. For businesses, the central lesson is straightforward: the decision about which patent claims to challenge may be just as consequential as the strength of the best invalidity argument.
Businesses should account for these developments when evaluating patent disputes, negotiating technology licenses, and making decisions about protecting or challenging valuable intellectual property.




Comments